2月13日晚间，国家医保局发布《医疗保障基金使用监督管理条例实施细则》(以下简称细则)，对2021 年5月起实施的《医疗保障基金使用监督管理条例》作出细化。 细则在医疗机构全流程监管手段中增加了视频监控；明确了通过减免费用、送东西等方式诱导他人虚假 就医属骗保。此外，细则还规范了新型支付方式下的违规认定、细化了处罚标准与裁量权，并在行刑衔 接流程方面进行了细化。 明确骗保新情形 《每日经济新闻》记者(以下简称每经记者)注意到，细则对"诱导他人冒名或者虚假就医、购药""以骗取 医疗保障基金为目的"概念进行了细化，减免费用、提供额外财物(服务)等行为均被纳入其中。 细则明确，定点医药机构及其工作人员通过说服、虚假宣传、减免费用、提供额外财物(服务)等方式诱 使引导他人冒名或者虚假就医、购药的，可以认定属于"诱导他人冒名或者虚假就医、购药"的情形。通 过虚假宣传、违规减免费用、提供额外财物(服务)等方式组织参保人员就医、购药，应当认定定点医药 机构存在"以骗取医疗保障基金为目的"的行为。 如何理解这一新增内容？ 资深医保专家田浩伶在接受每经记者文字采访时表示，近期曝光的骗保案件，暴露了仍有部分怀着侥幸 心理的定点医 ...

Core Viewpoint - The National Healthcare Security Administration has released detailed implementation rules for the Medical Security Fund Supervision and Management Regulations, enhancing the regulatory framework to combat fraudulent medical claims and improve oversight mechanisms [1][6]. Group 1: Regulatory Enhancements - The new rules introduce video monitoring as part of the comprehensive regulatory measures for medical institutions [1][4]. - It specifies that inducements such as fee reductions or gifts to encourage false medical claims are considered fraud [1][7]. - The rules clarify the identification of violations under new payment methods and refine penalties and discretionary powers [1][6]. Group 2: Fraud Prevention Measures - Medical institutions are urged to recognize the seriousness of participating in fraudulent activities, such as offering free services to lure patients into unnecessary treatments [3][9]. - Institutions should enhance their understanding of legal policies and ensure comprehensive training to avoid regulatory gaps [3][9]. - The implementation of a smart regulatory system is emphasized to ensure fair handling of violations [2][8]. Group 3: Collaborative Oversight Mechanisms - The new rules establish clearer responsibilities among various departments, enhancing collaborative efficiency in oversight [5][11]. - A regular information-sharing and joint enforcement mechanism is introduced, moving from fragmented efforts to coordinated actions [5][11]. - The rules provide quantifiable standards for identifying violations, improving the precision of enforcement [5][11]. Group 4: Strengthened Penalty Framework - The new regulations enhance the enforcement power of healthcare fund supervision, clearly defining legal consequences for violations [6][11]. - A closed-loop penalty execution system is established, ensuring that regulatory requirements are effectively implemented [6][11]. - The introduction of these detailed rules marks a new phase in the supervision of healthcare funds, providing stronger institutional safeguards for public healthcare finances [6][11].

Core Viewpoint - Multiple psychiatric hospitals in Xiangyang and Yichang, Hubei Province, have been exposed for illegally admitting patients and allegedly defrauding medical insurance funds, prompting the establishment of a joint investigation team by the provincial government [1][2]. Group 1: Investigation and Response - A joint investigation team, consisting of various provincial departments, has been formed to conduct in-depth investigations into the reported issues, with strict actions promised against verified misconduct [1][4]. - Following media reports, Xiangyang City has initiated a thorough investigation to uncover the extent of the violations, with a commitment to handle confirmed issues swiftly and legally [2][4]. Group 2: Fraudulent Practices - Hospitals are reportedly treating patients as "cash cows," fabricating treatment projects to extract funds from the medical insurance system, leading to significant financial losses for the insurance fund [2]. - Patients are often coerced into prolonged hospital stays, even after recovery, with reports of physical abuse by medical staff to maintain control over patients [2]. Group 3: Regulatory Measures - The National Medical Insurance Administration has announced ongoing efforts to combat fraud, emphasizing the need for strict oversight and comprehensive inspections across all provinces and medical institutions [4]. - The focus of these inspections will be on areas with high risks of fund misuse, including those with abnormally high hospitalization rates and significant complaints [4].

襄阳市医保局工作人员对智通财经表示，媒体报道相关信息已经收到，领导也在处理此事。目前事情刚 报道出来，后续尚需要进一步详细调查，包括去医院核实，如果属实的话肯定会依法依规进行处罚，会 对骗保的医院从重处理。 智通财经注意到，2024年9月，国家医保局也曾曝光精神病医院骗保的案例。重庆合川区康宁医院是精 神病专科医院，该院明码标价拉人住院，每拉1人住院付介绍费300元。医院定期给员工下达住院指标， 由医院社工部联络附近街镇居民住院，工作人员按联络住院的人数领取绩效奖励。该院社工部、护理 部、医保信息科员工均靠介绍他人住院获得奖励。该院还存在涉嫌虚假住院骗保、涉嫌虚构诊疗服务骗 保和涉嫌伪造检查检验报告骗保等问题。 报道称，只要住进医院，这些病人就成了医院眼中的"摇钱树"，医护人员利用他们的住院信息，虚构诊 疗项目，套取医保资金。原本用来"救命"的医保资金，日复一日地被以这种方式套取。住院病人人数越 多、住得越久，医院的"创收"也就越高。报道还介绍，这些精神病医院为了多挣钱，除了拉拢更多人住 院外，还会千方百计阻挠病人出院，不少病人明明病情康复却被迫住院数年，出院成为奢望。卧底期 间，记者也多次目睹了医护人员扇病 ...

Core Viewpoint - The National Healthcare Security Administration has announced five typical cases of fraud involving maternity insurance funds, highlighting the government's commitment to combatting fraudulent activities in the healthcare sector [1] Group 1: Fraudulent Activities - The cases primarily involve the fabrication and falsification of insured individuals' information and labor relationships to participate in maternity insurance [1] - There are instances of failure to accurately declare the maternity insurance payment base as required by law [1] - The submission of forged or altered medical records and receipts to fraudulently claim maternity insurance funds has been reported [1]

Core Viewpoint - The National Medical Insurance Administration has launched a "100-day action" to address prominent issues in medical insurance fund management, aiming to eliminate illegal practices related to the resale of medical insurance return drugs by designated institutions by December 31, 2025 [1] Group 1: Focus Areas of the Action - Comprehensive governance of the resale of medical insurance return drugs, targeting issues such as falsifying prescriptions, fraudulent use of medical insurance vouchers, and illegal sales by professional prescribers and insured individuals [2] - Special investigation into excessive prescription practices, monitoring abnormal prescription and purchase behaviors, and identifying potential collusion in obtaining medical insurance drugs [3] Group 2: Specific Issues Addressed - Special governance of maternity allowance fraud, focusing on the verification of false documentation, fictitious employment relationships, and inflated payment bases to recover misappropriated medical insurance funds [4] - Emphasis on increasing punitive measures against identified illegal activities, with a commitment to publicize cases and educate the public on the consequences of such fraud [4]

Core Viewpoint - The National Medical Insurance Administration is intensifying efforts to combat fraudulent activities related to medical insurance funds, emphasizing the importance of safeguarding public health resources and ensuring the sustainability of the medical insurance system [1][8]. Group 1: Fraud Cases - Case 1: In Shenzhen, an individual named Li exploited others' medical insurance accounts to sell drugs illegally, defrauding the medical insurance fund of 93,013.68 yuan, with total illegal transactions amounting to 169,025.00 yuan [1]. - Case 2: In Beijing, a couple named Yu and Wang were caught selling medical drugs at lower prices, acquiring drugs worth over 110,000 yuan, and were sentenced to 1 year and 2 months in prison [2]. - Case 3: In Hubei, two individuals, Qiu and Ke, misused their outpatient chronic disease benefits to sell drugs, resulting in a total fraud amount of 408,25.78 yuan [3]. - Case 4: In Shanghai, a retiree named Hu was found selling drugs purchased through medical insurance, leading to a recovery of 5,223.31 yuan in funds [4]. - Case 5: In Xinjiang, a retiree named Tan submitted fraudulent medical bills totaling 426,218.45 yuan over several years, resulting in a prison sentence of 3 years [5]. - Case 6: In Jilin, an individual named Gao fraudulently claimed reimbursement for medical expenses already covered by a third party, amounting to 27,394.69 yuan [6]. - Case 7: In Tianjin, Zhang was found to have used another person's medical insurance card to claim medical expenses of 11,284.99 yuan [7]. Group 2: Regulatory Actions - The National Medical Insurance Administration, in collaboration with various governmental departments, is conducting a nationwide crackdown on fraudulent activities, highlighting the importance of maintaining a high-pressure regulatory environment [1][8]. - The administration is utilizing big data and technology to monitor and identify suspicious activities related to medical insurance claims [2][4][6]. - There is a strong emphasis on educating the public about the legal implications of fraud and the importance of adhering to medical insurance regulations [8].

Core Viewpoint - The National Healthcare Security Administration (NHSA) is intensifying efforts to combat healthcare fraud, emphasizing the importance of safeguarding the medical insurance fund, which is crucial for public welfare and the sustainability of the healthcare system [1][8]. Summary by Cases Case 1: Shenzhen Fraud - A resident in Shenzhen, identified as Li, exploited others' medical insurance accounts to sell drugs illegally, defrauding the healthcare fund of 93,013.68 yuan. The accomplice, Wang, purchased these drugs for 169,025.00 yuan. Both were criminally detained, and Li was sentenced to 2 years and 4 months in prison [1]. Case 2: Beijing Drug Trafficking - A couple in Beijing, Yu and Wang, were caught selling healthcare drugs at a lower price after acquiring them from elderly individuals. The total value of the drugs involved exceeded 110,000 yuan. They received sentences of 1 year and 2 months, with a suspended sentence and a fine of 20,000 yuan [2]. Case 3: Hubei Abuse of Benefits - In Hubei, two individuals, Qiu and Ke, misused their outpatient chronic disease benefits to sell drugs, resulting in a total fraud amount of 408,25.78 yuan. Qiu was sentenced to 3 years and 9 months, while Ke received a 2-year sentence [3]. Case 4: Shanghai Resale of Drugs - A 74-year-old retiree in Shanghai, identified as Hu, was found reselling drugs purchased through the healthcare system. The NHSA recovered 5,223.31 yuan in funds and imposed a fine of 13,320.00 yuan [4]. Case 5: Xinjiang False Claims - A retiree in Xinjiang, identified as Tan, submitted fraudulent medical bills over 27 instances, defrauding the healthcare fund of 426,218.45 yuan. He was sentenced to 3 years in prison with a 4-year suspension and fined 50,000 yuan [5]. Case 6: Jilin Duplicate Claims - In Jilin, an individual named Gao attempted to claim reimbursement for medical expenses already covered by a third party, fraudulently obtaining 27,394.69 yuan. The case has been forwarded to law enforcement for further investigation [6]. Case 7: Tianjin Identity Fraud - In Tianjin, Zhang was found using another person's medical insurance card for medical services, defrauding the fund of 11,284.99 yuan. She was ordered to repay the amount and fined 22,569.98 yuan [7]. Regulatory Response - The NHSA is committed to enhancing regulatory measures and utilizing technology to track drug sales, aiming for a zero-tolerance policy against fraud. Citizens are encouraged to report any suspicious activities to protect the integrity of the healthcare fund [8].

Core Insights - The National Healthcare Security Administration released the "2024 National Medical Security Development Statistical Bulletin," highlighting key data on healthcare insurance in China [1] Group 1: Healthcare Insurance Participation and Financials - As of the end of 2024, the number of participants in the basic medical insurance scheme reached 1.32662 billion, maintaining a coverage rate of 95% [2] - Total revenue for the basic medical insurance fund (including maternity insurance) was 3.491337 trillion yuan, while total expenditures were 2.976403 trillion yuan, resulting in a surplus of 463.917 billion yuan for the year [2] Group 2: Employee Insurance and Maternity Benefits - The number of participants in employee medical insurance reached 379.4834 million, an increase of 8.537 million or 2.3% from the previous year, with over 104.575 million retirees covered [5] - The number of individuals enjoying maternity insurance benefits increased by 3.9638 million, a growth of 1.6%, with 36.908 million instances of benefits claimed, marking a 30.2% increase [6] Group 3: Fraud Prevention and Recovery - The healthcare system recovered 27.5 billion yuan in fraud cases, with 2,008 institutions confirmed for fraud, and 10,741 suspects arrested [8] Group 4: Drug Inclusion and Procurement - A total of 3,159 drugs are included in the 2024 National Basic Medical Insurance Drug List, with 91 new drugs added this year [9][10] - Since the establishment of the National Healthcare Security Administration in 2018, 835 drugs have been added to the insurance list, with 2.8 billion instances of drug reimbursement in 2024 [10] Group 5: Long-term Care Insurance - Participation in long-term care insurance reached 187.8634 million in 49 pilot cities, with the number of beneficiaries increasing from 835,000 in 2020 to 1.4625 million in 2024 [11] Group 6: Cross-Region Medical Services - In 2024, there were 397 million instances of cross-region medical services, with total costs amounting to 786.774 billion yuan [13]

Core Insights - The provincial medical insurance flying inspections are being initiated across various regions, focusing on the issue of "return drugs" and fraudulent practices in medical insurance [1][2][3] Group 1: Inspection Overview - The provincial flying inspections will cover all medical service behaviors and costs from January 1, 2023, to December 31, 2024, with the possibility of extending checks to previous years or 2025 [1] - The inspections are organized in a collaborative manner involving provincial and municipal levels, with teams typically consisting of around 50 members, including experts from various fields [2] Group 2: Focus Areas - Key areas of inspection include medical institutions, retail pharmacies, insured individuals, and medical insurance handling agencies, with specific attention on self-inspection results in nine medical fields [3] - The "return drug" issue is highlighted, with a focus on tracking drug traceability codes to combat illegal resale practices [3][4] Group 3: Regulatory Actions - The inspections will lead to immediate reporting to drug regulatory authorities for any discovered illegal activities, including the sale of return drugs and counterfeit medications [4] - The National Medical Insurance Administration has previously recovered over 8 billion yuan through similar inspections, demonstrating the effectiveness of these regulatory measures [2]